1 results match your criteria: "San Diego CyberKnife Center[Affiliation]"
Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Int J Radiat Oncol Biol Phys
April 2008
Radiosurgery Medical Group, Inc., San Diego CyberKnife Center, San Diego, CA 92123, USA.
Article Synopsis
- The study investigated the effectiveness of CyberKnife (CK) SBRT in approximating HDR brachytherapy doses for prostate cancer while comparing planning and patient outcomes.
- In a trial involving ten patients, CK SBRT showed similar planning target volume coverage to HDR, but with lower urethra radiation doses in most cases, indicating a potential for reduced toxicity.
- Four months post-treatment, patients exhibited a significant reduction in prostate-specific antigen levels, with manageable acute side effects mostly resolving within two months.